We use cookies to provide you with the best of services and customized features. By continuing to browse this website, you give your informed consent to our Cookie Policy.
Flashpoint Therapeutics has secured $10m in a seed funding round led by Saudi Arabian deep tech venture capital company Beta Lab to develop nanotechnology-enabled medicines.
